Terestigmine
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight | ||
Terestigmine is a cholinesterase inhibitor that has been studied for its potential use in the treatment of Alzheimer's disease and other neurodegenerative disorders. As a member of the carbamate class of compounds, Terestigmine functions by inhibiting the enzyme acetylcholinesterase, thereby increasing the concentration of acetylcholine in the synaptic cleft and enhancing cholinergic transmission.
Mechanism of Action[edit | edit source]
Terestigmine exerts its effects by binding to the active site of acetylcholinesterase, preventing the breakdown of acetylcholine. This results in prolonged action of acetylcholine at cholinergic synapses, which is beneficial in conditions characterized by reduced cholinergic activity, such as Alzheimer's disease.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of Terestigmine includes its absorption, distribution, metabolism, and excretion. It is typically administered orally, with a bioavailability that can be affected by factors such as food intake and gastrointestinal motility. Terestigmine is metabolized primarily in the liver, and its metabolites are excreted via the kidneys.
Clinical Applications[edit | edit source]
While Terestigmine has shown promise in preclinical studies, its clinical efficacy and safety profile are still under investigation. It is hypothesized to improve cognitive function in patients with Alzheimer's disease by enhancing cholinergic neurotransmission.
Side Effects[edit | edit source]
Common side effects associated with cholinesterase inhibitors like Terestigmine include nausea, vomiting, diarrhea, muscle cramps, and insomnia. These effects are generally dose-dependent and may be mitigated by adjusting the dosage.
Research and Development[edit | edit source]
Ongoing research is focused on optimizing the therapeutic window of Terestigmine, minimizing side effects, and exploring its potential use in other neurological conditions such as Parkinson's disease and myasthenia gravis.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
